College students of color not only face a disproportionate risk of contracting COVID-19, they are particularly vulnerable to its psychological damage — especially when the longtime struggle against inequality and the current financial crisis are factored in, said speakers at a virtual Harvard forum.

Looking at the public health effects, and perhaps mortality rate, from President Trump’s running dismissal of wearing face masks to minimize the spread of coronavirus.

Researchers have found that a targeted therapy with tocilizumab reduced mortality by 30 percent for critically ill COVID-19 patients when administered within the first two days of ICU admission.

Harvard Chan School’s Joseph Allen gives America an “F” on school reopening efforts, and says we’re in danger of losing thousands of virtual dropouts and wasting mild late summer/early autumn weather we could use to boost in-person learning.

A new Harvard course challenges students to use science to evaluate COVID-19 policies.

A new study shows that people who survive serious COVID-19 infections have long-lasting immune responses against the virus.

Study represents the most comprehensive scientific survey to date about the interrelationship between COVID-19 and cancer.

The international forum “Global Perspectives on COVID-19,” co-sponsored by Harvard Medical School, cited the importance of strong, coordinated government response as a key to stopping the novel coronavirus’ spread.

The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.

“Viral history” tool VirScan offers new insights into antibody response to SARS-CoV-2.